Loading provider…
Loading provider…
Hematology & Oncology Physician in Pembroke Pines, FL
NPI: 1447492913Primary Practice Location
MEMORIAL HOSPITAL WEST
703 N Flamingo Rd, Pembroke Pines, FL
Primary Employer
Memorial Hospital Miramar - Medical Offices
mhs.net
HQ Phone
Get M.D. Yehuda's Phone Numberphone_androidMobile
Get M.D. Yehuda's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2015 - 2027

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
University of Miami/Jackson Health System
Fellowship • Hematology and Medical Oncology
2012 - 2015
Residency • Internal Medicine
2009 - 2012
University of Miami, Miller School of Medicine
med.miami.edu
Medical School
Until 2009
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 85 | 278 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 37 | 91 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 21 | 25 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 19 | 44 |
Authors: Justin Watts, Ronan Swords, Mark Goodman, Francisco Vega-Vazquez, German Campuzano Zuluaga, Matthew Salzberg, Fernando Vargas Madueno
Journal: Am J Hematol
Publication Date: 2016-01-11
Authors: Somedeb Ball, Terrence Bradley, Justin Watts, Andrew Kuykendall, Jeffrey Lancet, Wassim Samra, Kendra Sweet, Onyee Chan, Rami Komrokji, Eric Padron, David Sallman, Chetasi Talati
Journal: Cancer
Publication Date: 2022-09-15
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: ABL001
Lead Sponsor: Seagen Inc.
Intervention / Treatment: DRUG: placebo, DRUG: azacitidine, DRUG: decitabine, DRUG: 33A
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Midostaurin